Tzu‐Wen Lien - Concepedia

Author

Tzu‐Wen Lien

National Health Research Institutes

Also Known As

Tzu-Wen Lien, Tzu‐Wen Lien

Publications

Citations

H-Index

Concepts

All Affiliations

National Health Research Institutes National Tsing Hua University National Yang Ming Chiao Tung University Pondicherry University National Defense Medical Center

About

Tzu‐Wen Lien is an author at National Health Research Institutes specializing in medicine, cancer research, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	532
2	Cell Biology	4	4	243
3	Natural Sciences	2	2	144
4	Biochemistry	2	2	151
5	Microbiology	1	1	138

Tzu‐Wen Lien

Publications

994

Citations

H-Index

Page 1

	Year	Citations
Haemolymph parameters of Pacific white shrimp (Litopenaeus vannamei) infected with Taura syndrome virus Yen-Ling Song, Chun I. Yu, Tzu‐Wen Lien, Fish & Shellfish Immunology Diagnostic VirologyPacific White ShrimpLitopenaeus VannameiPathogenesisPathology	2003	138
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system Der-Ren Hwang, Yu-Shan Wu, Chun-Wei Chang, Bioorganic & Medicinal Chemistry Sesquiterpene LactonesBiochemistryMedicineAnti-viral ActivityAntiviral Drug Development	2005	116
Design and Synthesis of Tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency Chia-Hsien Wu, Mohane Selvaraj Coumar, Chang-Ying Chu, Journal of Medicinal Chemistry Kinase InhibitorsMolecular BiologySide Chain ChiralityMaximal PotencyPharmaceutical Chemistry	2010	109
Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists: Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities I-Lin Lu, Chien-Fu Huang, Yi‐Hui Peng, Journal of Medicinal Chemistry	2006	98
Novel Indole-Based Peroxisome Proliferator-Activated Receptor Agonists: Design, SAR, Structural Biology, and Biological Activities Neeraj Mahindroo, Chien-Fu Huang, Yi-Huei Peng, Journal of Medicinal Chemistry	2005	87
Structure-Based Drug Design of Novel Aurora Kinase A Inhibitors: Structural Basis for Potency and Specificity Mohane Selvaraj Coumar, Jiun-Shyang Leou, Paritosh Shukla, Journal of Medicinal Chemistry	2009	74
Indol-1-yl Acetic Acids as Peroxisome Proliferator-Activated Receptor Agonists: Design, Synthesis, Structural Biology, and Molecular Docking Studies Neeraj Mahindroo, Chiung-Chiu Wang, Chun-Chen Liao, Journal of Medicinal Chemistry	2006	71
Fast-Forwarding Hit to Lead: Aurora and Epidermal Growth Factor Receptor Kinase Inhibitor Lead Identification Mohane Selvaraj Coumar, Chang‐Ying Chu, Cheng‐Wei Lin, Journal of Medicinal Chemistry Lead ConversionHit IdentificationChemoprevention StrategyLead IdentificationParallel Reactors	2010	68
Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells Huan-Chih Chiu, Ding-Li Chou, Chin-Ting Huang, Biochemical Pharmacology Cell RegulationMedicineStat3 ActivityTumor SuppressorRadiation Oncology	2011	54
Bioassay‐guided purification and identification of PPAR<i>α</i>/<i>γ</i> agonists from <i>Chlorella sorokiniana</i> Yu‐Cheng Chou, Ekambaranellore Prakash, Chien‐Fu Huang, Phytotherapy Research BiosynthesisBioorganic ChemistryBiotransformationBiochemistryBioassay-guided Isolation	2008	35

Page 1